Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Amoxycillin (125mg) + Clavulanic Acid (25mg)
Therapeutic Category
Antibacterials, Antibiotic, Pediatrics
Dosage Form
Injection
Packaging Type
Vial + Water
Packaging
vial
Price
₹74/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Moxyplit 150 Injection is a potent combination of amoxicillin and clavulanic acid, specifically formulated to combat various bacterial infections. Amoxicillin, a broad-spectrum penicillin antibiotic, works by inhibiting the growth of bacteria, while clavulanic acid serves as a beta-lactamase inhibitor, enhancing the effectiveness of amoxicillin against resistant strains. This synergistic formulation is designed for parenteral administration, ensuring rapid absorption and efficacy in treating a range of infections, including those affecting the respiratory tract, urinary system, skin, and soft tissues.
Moxyplit 150 is especially useful in cases where infections are caused by beta-lactamase producing bacteria that may otherwise resist treatment with amoxicillin alone. This makes it a vital option in clinical settings, particularly for patients who may be unable to tolerate oral medications due to severe illness or gastrointestinal complications.
The injection is typically administered under the supervision of a healthcare professional, ensuring proper dosing and monitoring for any potential reactions. Its formulation allows for precise dosage adjustments based on the severity of the infection and the patient’s overall health condition.
Common side effects may include gastrointestinal disturbances, allergic reactions, and local injection site reactions. Monitoring for serious side effects is essential.
Moxyplit 125 Injection is indicated for the treatment of moderate to severe infections caused by susceptible bacteria, particularly those resistant to other antibiotics.
This medication should be used under medical supervision, and patients should inform their healthcare provider of any known allergies or existing medical conditions before administration.
Store Moxyplit 125 Injection at controlled room temperature, away from direct sunlight and moisture.
Composition : Amoxycillin (250mg) + Clavulanic Acid (50mg)
Composition : Amoxycillin (500mg) + Clavulanic Acid (100mg)
Composition : Arteether (150mg) Injection
Composition : Artesunate (120mg) Injection
Composition : Artesunate (60mg) Injection
Composition : Azithromycin (500mg) Injection
Composition : Brivaracetam (10mg) Injection
Composition : Cefepime (1000mg) Injection
Composition : Cefepime (1000mg) + Tazobactum (125mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This injectable antibiotic combination has strong demand in the hospital and anti-infective segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on injectable antibiotic and critical care portfolios.
Medical distributors and agencies can benefit from consistent hospital demand for treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, post-surgical infections, and severe bacterial infections. Amoxycillin helps eliminate bacteria, while Clavulanic Acid improves effectiveness by overcoming bacterial resistance, strengthening a reliable injectable antibiotic portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this injectable antibiotic combination with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong hospital and institutional demand, high anti-infective prescription flow, ICU and emergency care usage, reliable supply chain support, and good margins when partnering for this injectable antibiotic product.
Medical distributors, stockists, and wholesalers interested in this injectable antibiotic combination can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.